Protective effects of catalpol on oligodendrocyte death and myelin breakdown in a rat model of chronic cerebral hypoperfusion

Neuroscience Letters

Volumn 497, Issue 1, 2011, Pages 22-26

  Cai, Qi Yan ^a   Chen, Xing Shu ^a   Zhan, Xiao Li ^a   Yao, Zhong Xiang ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Catalpol; Chronic cerebral hypoperfusion; CREB; OLG; WMLs

Indexed keywords

CATALPOL; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; PROTEIN BCL 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; BRAIN PERFUSION; CAROTID ARTERY LIGATION; CHRONIC DISEASE; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG EFFECT; MALE; MEMORY DISORDER; MYELIN SHEATH; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SHAM PROCEDURE; SPATIAL MEMORY; WHITE MATTER; WISTAR RAT;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; BRAIN; BRAIN ISCHEMIA; CREB-BINDING PROTEIN; DISEASE MODELS, ANIMAL; IMMUNOHISTOCHEMISTRY; MALE; MAZE LEARNING; MYELIN SHEATH; NEUROPROTECTIVE AGENTS; OLIGODENDROGLIA; PHOSPHORYLATION; QUATERNARY AMMONIUM COMPOUNDS; RATS; RATS, WISTAR; RECOVERY OF FUNCTION; SIGNAL TRANSDUCTION;

EID: 79955984394     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.04.013     Document Type: Article

References (26)

1. Benito E., Barco A. CREB's control of intrinsic and synaptic plasticity: implications for CREB-dependent memory models. Trends Neurosci. 2010, 33:230-240.
2. Casaccia-Bonnefil P. Cell death in the oligodendrocyte lineage: a molecular perspective of life/death decisions in development and disease. Glia 2000, 29:124-135.
3. Farkasa E., Luiten P.G., Bari F. Permanent, bilateral common carotid artery occlusion in the rat: a model for chronic cerebral hypoperfusion-related neurodegenerative diseases. Brain Res. Rev. 2007, 54:162-180.
4. Han B.H., Xu D., Choi J., Han Y., Xanthoudakis S., Roy S. Selective, reversible caspase-3 inhibitor is neuroprotective and reveals distinct pathways of cell death after neonatal hypoxic-ischemic brain injury. J. Biol. Chem. 2002, 277:30128-30136.
5. Hisahara S., Shoji S., Okano H., Miura M. ICE/ced-3 family executes oligodendrocyte apoptosis by tumor necrosis factor. J. Neurochem. 1997, 69:10-20.
6. Hisahara S., Okano H., Miura M. Caspase-mediated oligodendrocyte cell death in the pathogenesis of autoimmune demyelination. Neurosci. Res. 2003, 46:387-397.
7. Ihara M., Tomimoto H., Kinoshita M., Oh J., Noda M., Wakita H., Akiguchi I., Shibasaki H. Chronic cerebral hypoperfusion induces MMP-2 but not MMP-9 expression in the microglia and vascular endothelium of white matter. J. Cereb. Blood Flow Metab. 2001, 21:828-834.
8. Jellinger K.A. The enigma of vascular cognitive disorder and vascular dementia. Acta. Neuropathol. 2007, 113:349-388.
9. Li D.Q., Duan Y.L., Bao Y.M., Liu C.P., Liu Y., An L.J. Neuroprotection of catalpol in transient global ischemia in gerbils. Neurosci. Res. 2004, 50:169-177.
10. Li Y.C., Bao Y.M., Jiang B., Wang Z., Liu Y.X., Zhang C., An L.J. Catalpol protects primary cultured astrocytes from in vitro ischemia-induced damage. Int. J. Dev. Neurosci. 2008, 26:309-317.
11. Liu J., He Q.J., Zou W., Wang H.X., Bao Y.M., Liu Y.X. Catalpol increases hippocampal neuroplasticity and up-regulates PKC and BDNF in the aged rats. Brain Res. 2006, 1123:68-79.
12. Mir F., Le-Breton G.C. A novel nuclear signaling pathway for thromboxane A2 receptors in oligodendrocytes: evidence for signaling compartmentalization during differentiation. Mol. Cell. Biol. 2008, 28:6329-6341.
13. O'Sullivan M. Leukoaraiosis Pract. Neurol. 2008, 8:26-38.
14. Redondo C., Lopez-Toledano M.A., Lobo M.V., Gonzalo-Gobernado R., Reimers D., Herranz A.S., Paino C.L., Bazan E. Kainic acid triggers oligodendrocyte precursor cell proliferation and neuronal differentiation from striatal neural stem cells. J. Neurosci. Res. 2007, 85:1170-1182.
15. Saini H.S., Gorse K.M., Boxer L.M., Sato-Bigbee C. Neurotrophin-3 and a CREB-mediated signaling pathway regulate Bcl-2 expression in oligodendrocyte progenitor cells. J. Neurochem. 2004, 89:951-961.
16. Tomimoto H., Ihara M., Wakita H., Ohtani R., Lin J.X., Akiguchi I., Kinoshita M., Shibasaki H. Chronic cerebral hypoperfusion induces white matter lesions and loss of oligodendroglia with DNA fragmentation in the rat. Acta. Neuropathol. (Berl.) 2003, 106:527-534.
17. Wakita H., Tomimoto H., Akiguchi I., Matsuo A., Lin J.X., Ihara M., McGeer P.L. Axonal damage and demyelination in the white matter after chronic cerebral hypoperfusion in the rat. Brain Res. 2002, 924:63-70.
18. Walker E.J., Rosenberg G.A. Divergent role for MMP-2 in myelin breakdown and oligodendrocyte death following transient global ischemia. J. Neurosci. Res. 2010, 88:764-773.
19. Wang J., Zhang H.Y., Tang X.C. Huperzine improves chronic inflammation and cognitive decline in rats with cerebral hypoperfusion. J. Neurosci. Res. 2010, 88:807-815.
20. Wang C.F., Li D.Q., Xue H.Y., Hu B. Oral supplementation of catalpol ameliorates diabetic encephalopathy in rats. Brain Res. 2010, 1307:158-165.
21. Watanabe T., Zhang N., Liu M., Tanaka R., Mizuno Y., Urabe T. Cilostazol protects against brain white matter damage and cognitive impairment in a rat model of chronic cerebral hypoperfusion. Stroke 2006, 37:1539-1945.
22. Waxman S.G., Swadlow H.A. Ultrastructure of visual callosal axons in the rabbit. Exp. Neurol. 1976, 53:115-127.
23. Yoshioka A., Yamaya Y., Saiki S., Kanemoto M., Hirose G., Beesley J., Pleasure D. Non-N-methyl-d-aspartate glutamate receptors mediate oxygen-glucose deprivation-induced oligodendroglial injury. Brain Res. 2000, 854:207-215.
24. Yu H., Oh-Hashi K., Tanaka T., Sai A., Inoue M., Hirata Y., Kiuchi K. Rehmannia glutinosa induces glial cell line-derived neurotrophic factor gene expression in astroglial cells via cPKC and ERK1/2 pathways independently. Pharmacol. Res. 2006, 54:39-45.
25. Zhang X.L., Zhang A.H., Jiang B. Further pharmacological evidence of the neuroprotective effect of catalpol from Rehmannia glutinosa. Phytomedicine 2008, 15:484-490.
26. Zhao J.S., Ye Z.B., Zhao T., Chen J.J., Zhong J.G., Wang L. Clinical and pathological experimental study on deferring senile effects of Liuwei Dihuang Pill. World Science and Technology/Modernization of Traditional Chinese Medicine and Materia Medica 2006, vol. 8. pp. 117-122.